Abstract | BACKGROUND: PATIENTS AND METHODS: We assessed the frequency, characteristics and predictive factors of second cancers in 230 patients with Waldenström macroglobulinemia (WM) and compared the incidence of second cancers in WM with that of an age- and sex-matched control population. RESULTS: CONCLUSIONS: WM patients are at higher risk of second cancers as compared with the general population. The sample size does not allow firm conclusions about the effect of therapy on the development of second cancers.
|
Authors | M Varettoni, A Tedeschi, L Arcaini, C Pascutto, E Vismara, E Orlandi, F Ricci, A Corso, A Greco, S Mangiacavalli, M Lazzarino, E Morra |
Journal | Annals of oncology : official journal of the European Society for Medical Oncology
(Ann Oncol)
Vol. 23
Issue 2
Pg. 411-5
(Feb 2012)
ISSN: 1569-8041 [Electronic] England |
PMID | 21525403
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents
(adverse effects)
- Female
- Humans
- Incidence
- Male
- Middle Aged
- Neoplasms, Second Primary
(epidemiology, etiology)
- Retrospective Studies
- Risk Factors
- Waldenstrom Macroglobulinemia
(complications, drug therapy)
|